{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "Amount",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "uaz:UAZ05309",
      "entity_text" : "sICAM1",
      "entity_type" : "protein"
    },
    "hypothesis_information" : false,
    "context" : {
      "Species" : [ "taxonomy:9606" ],
      "TissueType" : [ "tissuelist:TS-0627" ],
      "Organ" : [ "uberon:UBERON:0000479" ],
      "CellType" : [ "cl:CL:0000127" ]
    }
  },
  "verbose_text" : "Our finding of elevated plasma sICAM1 in chronically ill people with schizophrenia supports studies showing elevated peripheral sICAM1 levels in patients receiving antipsychotic medication [XREF_BIBR], and patients with schizophrenia who have a putative disruption of the BBB [XREF_BIBR].",
  "reading_complete" : "2020-08-08T19:05:17Z",
  "reader_type" : "machine",
  "reading_started" : "2020-08-08T18:59:25Z",
  "trigger" : "levels",
  "evidence" : [ "sICAM1 levels" ],
  "pmc_id" : "7156343",
  "score" : 0
}